The importance of the TGFβRIII-p38MAPK-Rb signaling axis in maintaining dormancy was evaluated in patients with prostate cancer; lower TGFβRIII expression correlated with increased metastatic potential and decreased survival rates [89]. This evidence concerns the gene RB1 and Familial prostate cancer.